14-05-2025
OMNY Health Is Healthcare AI For Millions, Not Just Millionaires
Inside the capital-efficient startup using real-world patient data to train AI tools for healthcare access, equity, and impact
OMNY Health Founder & CEO Mitesh Rao, MD
OMNY Health
While Silicon Valley pours billions into longevity tech and concierge medicine for the ultra-wealthy, OMNY Health is building something far more radical: a data infrastructure that can actually improve healthcare for everyone. The Atlanta-based healthcare AI startup is tackling real-world challenges like chronic disease, hospital readmissions, and clinical trial diversity—issues that affect millions of Americans, not just the privileged few.
By democratizing access to rich, representative clinical data, OMNY empowers the next wave of healthcare AI solutions to scale across the system, from safety-net hospitals to nationwide research initiatives. Its platform gives health tech developers access to more than 85 million patient records, including over 4 billion unstructured clinical notes, offering a level of depth and breadth that was previously out of reach for most startups.
We're at an inflection point in healthcare. Artificial intelligence is advancing rapidly, but the data it feeds on remains fractured, shallow, and unevenly representative.
Despite billions poured into AI tools for diagnostics, documentation, and drug discovery, most models still fail to generalize outside controlled test environments. According to a recent Optum survey, 41% of healthcare executives say "data readiness" is the single biggest barrier to scaling AI. In other words, AI isn't stuck because of a lack of ideas—it's stuck because the inputs are broken.
That's the challenge OMNY Health is taking on. Last week, it announced the addition of more than 300 clinical assessment measures to its data platform, spanning 10 medical specialties—from neurology and gastroenterology to autoimmune disease and cardiology. These validated indices track everything from disease progression to treatment response, filling in the blind spots that plague traditional claims datasets and specialty registries.
'Our network of more than 85 million patients represents every diverse aspect of the American healthcare experience,' said Dr. Mitesh Rao, CEO and co-founder of OMNY Health. 'OMNY's real-world data will now be the deepest and most comprehensive source of clinical information for the nation.'
The OMNY Health platform
OMNYHealth
Dr. Rao added, 'As an emergency medicine physician and health services researcher, I saw firsthand how siloed data was across systems and knew there had to be a better way to streamline data sharing across the industry. Later, during my time as chief patient safety officer at Stanford Health Care, I focused on improving the outcomes of patients through research and realized that healthcare lacked a real, scalable solution. That's when I turned to entrepreneurship alongside my co-founder, Sean O'Brien, an expert in software and regulated data, to help bring my vision to life—a national data layer that grants researchers and physicians access to the comprehensive and timely information they need to make more informed decisions without risking patient safety.'
'With the addition of these deep clinical measures, we're capturing healthcare outcomes at an unprecedented level of granularity,' he continued. 'This positions OMNY as the most comprehensive source of real-world clinical data in the U.S.—laying the foundation not just for patient-centered research, but for the next generation of healthcare analytics and AI-driven models.'
OMNY Health's platform offers seamless integration with healthcare systems, enabling the aggregation of more than eight years of real-world clinical data. The data spans all 50 states, giving developers a truly national lens on care delivery trends, gaps, and outcomes.
Crucially, OMNY provides filters and tooling that help AI developers target specific patient populations and clinical scenarios, reducing bias and improving model performance. It's a foundational layer for more responsible, inclusive AI development in healthcare.
With over 4 billion clinical notes and rich metadata, OMNY's data trove unlocks insights buried deep in unstructured formats like physician dictations, discharge summaries, and imaging reports. This access is game-changing for AI startups and research teams, enabling faster training cycles, real-world validation, and broader scalability.
OMNY isn't just selling data—it's fueling innovation. The company has partnered with leading AI-driven health tech firms such as QuantHealth, which focuses on AI-powered clinical trial simulations, and Atropos Health, a leader in generating personalized real-world evidence at the point and pace of care. These collaborations exemplify how OMNY's infrastructure can accelerate everything from drug development to care optimization.
By bridging the gap between raw data and usable intelligence, OMNY is powering tools that predict patient outcomes, streamline documentation, and help researchers better understand treatment efficacy in diverse populations.
'As we see continued investment in AI solutions for healthcare, the technology's effectiveness is entirely dependent upon the quality of the data it's fed,' said Kevin Ryan, founder and CEO of AlleyCorp. 'By continuing to rapidly scale its network of real-world data, OMNY Health is building AI's essential foundation for success—a pivotal first step in paving the way for the innovation of safer and more equitable solutions that improve healthcare outcomes.'
In late 2022, OMNY raised a $17 million Series B round to expand its platform and grow its network. The raise, led by existing and new strategic investors, signaled growing recognition of the company's role as a key enabler in AI health innovation.
Unlike many data providers, OMNY focuses on longitudinal, de-identified data that supports both research and product deployment. Its regulatory and compliance framework makes it easy for customers to start building without navigating red tape or reinventing infrastructure.
What makes OMNY's growth even more striking is how much it has achieved with relatively little capital. While peers like Truveta have raised more than $320 million to date, OMNY has scaled to a national footprint with a fraction of that funding, underscoring the capital efficiency of its model and the market's appetite for leaner, more flexible data solutions.
OMNY Health presents various research findings from its extensive data network this week at ISPOR in Montreal. The conference, organized by the Professional Society for Health Economics and Outcomes Research, focuses on empowering data-driven, patient-centered decision-making that leads to more equitable, accessible, and effective healthcare solutions.
OMNY's release of more than 300 new measures comes just weeks after its announcement of adding 4 billion unstructured notes—a move that unlocked troves of buried insights. With that historical depth and specialty coverage, OMNY is becoming more than a data company—it's a healthcare platform in disguise.
Algorithms alone won't shape the future of medicine. It will be shaped by how well we can translate messy, fragmented health data into structured, accessible intelligence.
OMNY's bet is clear: AI won't transform healthcare until we transform the data first.
And if they're right, the most valuable tech companies in healthcare may not be the ones building the models, but the ones building the map.
As AI rapidly reshapes the healthcare industry, the quality and equity of the underlying data will define who benefits—and who gets left behind. OMNY is betting that scale, diversity, and responsible data access will be the difference between AI that reinforces healthcare inequality and AI that helps fix it.
With its strategy of building a transformative platform that prioritizes inclusivity and everyday impact, OMNY Health is emerging not just as a data vendor but as a foundational player in the future of medicine.
